Collegium Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Collegium Pharmaceutical has a total shareholder equity of $234.3M and total debt of $867.2M, which brings its debt-to-equity ratio to 370.2%. Its total assets and total liabilities are $1.6B and $1.4B respectively. Collegium Pharmaceutical's EBIT is $217.7M making its interest coverage ratio 4. It has cash and short-term investments of $145.0M.
Key information
370.2%
Debt to equity ratio
US$867.21m
Debt
| Interest coverage ratio | 4x |
| Cash | US$144.96m |
| Equity | US$234.28m |
| Total liabilities | US$1.40b |
| Total assets | US$1.64b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 354's short term assets ($443.8M) do not cover its short term liabilities ($459.4M).
Long Term Liabilities: 354's short term assets ($443.8M) do not cover its long term liabilities ($941.4M).
Debt to Equity History and Analysis
Debt Level: 354's net debt to equity ratio (308.3%) is considered high.
Reducing Debt: 354's debt to equity ratio has increased from 13.6% to 370.2% over the past 5 years.
Debt Coverage: 354's debt is well covered by operating cash flow (22.3%).
Interest Coverage: 354's interest payments on its debt are well covered by EBIT (4x coverage).